Jane Street
CADL icon

Jane Street’s Candel Therapeutics CADL Stock Holding History

Jane Street’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,799
Closed -$58.8K – 11670
2025
Q4 		$61K Buy
+10,799
New +$58.1K ﹤0.01% 10430
2025
Q1 		– Sell
-16,572
Closed -$135K – 9502
2024
Q4 		$144K Sell
16,572
-16,222
-49% -$95.9K ﹤0.01% 8604
2024
Q3 		$227K Buy
32,794
+20,834
+174% +$129K ﹤0.01% 8461
2024
Q2 		$74.2K Buy
+11,960
New +$89.8K ﹤0.01% 8833
2023
Q1 		– Sell
-13,425
Closed -$24K – 9083
2022
Q4 		$24K Buy
+13,425
New +$26.6K ﹤0.01% 8563

Other funds holding CADL

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $617M AUM 69.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jane Street's CADL Position: Q1 2026 in Review

Jane Street sold out of Candel Therapeutics (CADL) in Q1 2026, closing a stake of 10,799 shares — an estimated $58.8K sold.

Jane Street first reported a position in CADL in Q4 2022 and held it in 5 quarters. The position peaked at $227K in Q3 2024. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • Jane Street reported no remaining Candel Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 10,799 Candel Therapeutics shares in Q1 2026, an estimated $58.8K.
  • Jane Street first reported a position in Candel Therapeutics in Q4 2022 and held it in 5 quarters.
  • Jane Street's Candel Therapeutics position peaked at $227K in Q3 2024.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.